Home LiteratureArticle Details
PMID: 7944953 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein.

Archives of virology ·Vol. 137 ·No. 3-4 ·1994-00-00 ·Pages 315-26

Falconar AK, Young PR, Miles MA

Abstract

The reactions of a panel of 34 mouse monoclonal antibodies (MAbs) specific for the dengue-2 virus nonstructural-1 glycoprotein (NS1), were analysed using 174 overlapping synthetic nonameric peptides covering the entire sequence. Using this methodology, four epitopes were identified. One pair of MAbs, which defined a dengue-2/4 virus subcomplex epitope (24C: amino acids 299-309) using native NS1 proteins, showed the same reaction pattern with synthetic peptides containing the corresponding NS1 sequences of each virus serotype. One amino acid substitution, present in the sequences from the dengue-1/3 virus subcomplex abrogated almost all reaction by these MAbs. A dengue complex epitope (LX1: amino acids 111-121) was also located and peptides containing the sequences of each serotype were shown to contain only antigenically silent amino-acid substitutions. In contrast, MAbs which defined a dengue type-specific epitope (LD2: amino acids 25-33) and another dengue subcomplex epitope (24A: amino acids 61-69) failed to show the same reaction profiles using peptides of each serotype, suggesting that these determinants were partially dependent upon conformation. The LX1 epitope is a good candidate for further trials aimed at generating cross-protective immune responses to these viruses without the risk of antibody-dependent enhancement.

MeSH Terms
Amino Acid Sequence Antibodies, Monoclonal Blotting, Western Dengue Virus/immunology Enzyme-Linked Immunosorbent Assay Epitope Mapping Glycoproteins/immunology Molecular Sequence Data Peptide Fragments/chemical synthesis,immunology Viral Nonstructural Proteins/immunology
Chemicals
Antibodies, Monoclonal Glycoproteins NS1 protein, Dengue virus type 2 Peptide Fragments Viral Nonstructural Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Falconar A K
Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, London, U.K.
Young P R
Miles M A
References (33)
33 references, click to expand
  1. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus.
    Virology. 1993 Jun;194(2):769-80 PMID: 8389081
  2. Epitopes on protein antigens: misconceptions and realities.
    Cell. 1990 May 18;61(4):553-6 PMID: 1693095
  3. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    J Immunol. 1985 Oct;135(4):2805-9 PMID: 4031501
  4. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever.
    Am J Trop Med Hyg. 1991 May;44(5):481-93 PMID: 2063952
  5. Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses.
    Virology. 1988 Jan;162(1):167-80 PMID: 2827375
  6. From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.
    J Infect Dis. 1988 May;157(5):1105-11 PMID: 2452218
  7. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli.
    J Gen Virol. 1990 Sep;71 ( Pt 9):2107-14 PMID: 1698924
  8. Profiles of antibody-dependent enhancement of dengue virus type 2 infection.
    Microb Pathog. 1987 Oct;3(4):231-7 PMID: 3504546
  9. Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells.
    Virology. 1989 Apr;169(2):354-64 PMID: 2523178
  10. The XXth century dengue pandemic: need for surveillance and research.
    World Health Stat Q. 1992;45(2-3):292-8 PMID: 1462664
  11. Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1.
    J Virol Methods. 1990 Dec;30(3):323-32 PMID: 2150838
  12. Human antibody to dengue soluble complement-fixing (SCF) antigens.
    J Immunol. 1973 Dec;111(6):1804-9 PMID: 4201557
  13. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer.
    Virology. 1988 Jan;162(1):187-96 PMID: 2827377
  14. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.
    J Gen Virol. 1987 Mar;68 ( Pt 3):853-7 PMID: 3819700
  15. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever.
    Am J Trop Med Hyg. 1989 Apr;40(4):444-51 PMID: 2712199
  16. Three-dimensional structure of membrane and surface proteins.
    Annu Rev Biochem. 1984;53:595-623 PMID: 6383201
  17. Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain).
    Gene. 1989 Feb 20;75(2):197-211 PMID: 2714651
  18. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Virology. 1992 Apr;187(2):480-91 PMID: 1372140
  19. The conformational specificity of viral epitopes.
    FEMS Microbiol Lett. 1992 Dec 15;100(1-3):483-7 PMID: 1282485
  20. Study of anti-dengue NS1 antibody by western blot.
    J Med Virol. 1990 Oct;32(2):102-8 PMID: 2149144
  21. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
    J Gen Virol. 1988 Aug;69 ( Pt 8):2101-7 PMID: 3404125
  22. Strategies for epitope analysis using peptide synthesis.
    J Immunol Methods. 1987 Sep 24;102(2):259-74 PMID: 2443575
  23. Cognitive features of continuous antigenic determinants.
    J Mol Recognit. 1988 Feb;1(1):32-41 PMID: 2483922
  24. Complete nucleotide sequence of dengue type 3 virus genome RNA.
    Virology. 1990 Jun;176(2):643-7 PMID: 2345967
  25. Sequence of the dengue virus type 2 (strain PR-159) NS1 gene and comparison with its vaccine derivative.
    Nucleic Acids Res. 1993 Apr 11;21(7):1668 PMID: 8479921
  26. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.
    J Gen Virol. 1989 Aug;70 ( Pt 8):2037-49 PMID: 2549181
  27. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
    Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9 PMID: 2665015
  28. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature.
    Virology. 1990 Feb;174(2):479-93 PMID: 2129562
  29. Comparative analysis of the NS 1 gene sequences of dengue-1 viruses prototype Hawaii strain and Thai isolate TH-Sman, and determination of the intratypic variation of NS 1 protein among dengue-1 viruses.
    Arch Virol. 1993;131(3-4):447-54 PMID: 8347083
  30. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Virology. 1993 Jan;192(1):132-41 PMID: 8517015
  31. Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1.
    J Gen Virol. 1991 Apr;72 ( Pt 4):961-5 PMID: 1849979
  32. Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major nonstructural protein NS1.
    Virology. 1987 Nov;161(1):262-7 PMID: 3672932
  33. The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins.
    Virology. 1987 Aug;159(2):217-28 PMID: 3039728
Article Info
Journal
Archives of virology
Abbr.
Arch Virol
ISSN
0304-8608
Published
1994-00-00
Pages
315-26
Language
English
Region
Austria
NLM ID
7506870
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com